Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Richard Green W, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:413. https://doi.org/10.1016/S0161-6420(83)34604-2.

Article CAS PubMed Google Scholar

Pellegrini M, Bernabei F, Barbato F, Arpinati M, Giannaccare G, Versura P, et al. Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation. Am J Ophthalmol. 2021;227:2534. https://doi.org/10.1016/J.AJO.2021.02.022.

Article PubMed Google Scholar

Bray LC, Carey PJ, Proctor SJ, Evans RGB, Hamilton PJ, Carey TPJ. Ocular complications of bone marrow transplantation. Britishlournal Ophthalmol. 1991;75:6114.

CAS Google Scholar

Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15:5037. https://doi.org/10.1097/01.ICU.0000143684.22362.46.

Article PubMed Google Scholar

Sinha S, Singh RB, Dohlman TH, Taketani Y, Yin J, Dana R. Prevalence and risk factors associated with corneal perforation in chronic ocular graft-versus-host-disease. Cornea. 2020. https://doi.org/10.1097/ICO.0000000000002526.

Sinha S, Singh RB, Dohlman TH, Wang M, Taketani Y, Yin J, et al. Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease. Am J Ophthalmol. 2020;218:296303. https://doi.org/10.1016/j.ajo.2020.05.035.

Article PubMed Google Scholar

Singh RB, Yuksel E, Sinha S, Wang S, Taketani Y, Luznik Z, et al. Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease. Ocul Surf. 2022;26:138. https://doi.org/10.1016/j.jtos.2022.07.001.

Article PubMed Google Scholar

Wang S, Singh RB, Yuksel E, Musayeva A, Sinha S, Taketani Y, et al. Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy. Ocul Surf. 2022;26:1427. https://doi.org/10.1016/J.JTOS.2022.07.005.

Article PubMed Google Scholar

Chen Y, Wang S, Alemi H, Dohlman T, Dana R. Immune regulation of the ocular surface. Exp Eye Res. 2022;218:109007 https://doi.org/10.1016/J.EXER.2022.109007.

Article CAS PubMed PubMed Central Google Scholar

Foulsham W, Coco G, Amouzegar A, Chauhan SK, Dana R. When clarity is crucial: regulating ocular surface immunity. Trends Immunol. 2018;39:288301.

Article CAS PubMed Google Scholar

Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296 https://doi.org/10.1182/BLOOD-2011-06-364265.

Article CAS PubMed PubMed Central Google Scholar

Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 2011;117:3214 https://doi.org/10.1182/BLOOD-2010-08-302109.

Article CAS PubMed PubMed Central Google Scholar

Hill GR, Ferrara JLM. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95:27549. https://doi.org/10.1182/BLOOD.V95.9.2754.009K25_2754_2759.

Article CAS PubMed Google Scholar

Carapito R, Jung N, Kwemou M, Untrau M, Michel S, Pichot A, et al. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. Blood. 2016;128:197986. https://doi.org/10.1182/BLOOD-2016-05-719070.

Article CAS PubMed PubMed Central Google Scholar

Martin PJ, Levine DM, Storer BE, Warren EH, Zheng X, Nelson SC, et al. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 2017;129:7918. https://doi.org/10.1182/BLOOD-2016-09-737700.

Article CAS PubMed PubMed Central Google Scholar

Klmbt V, Wohlfeil SA, Schwab L, Hlsdnker J, Ayata K, Apostolova P, et al. A novel function for P2Y2 in myeloid recipient-derived cells during graft-versus-host disease. J Immunol. 2015;195:5795804. https://doi.org/10.4049/JIMMUNOL.1501357.

Article PubMed Google Scholar

Reinhardt K, Foell D, Vogl T, Mezger M, Wittkowski H, Fend F, et al. Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host disease. J Immunol. 2014;193:335565. https://doi.org/10.4049/JIMMUNOL.1400983.

Article CAS PubMed Google Scholar

Arafat SN, Robert MC, Abud T, Spurr-Michaud S, Amparo F, Dohlman CH, et al. Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients. Am J Ophthalmol. 2017;176:4652. https://doi.org/10.1016/J.AJO.2016.12.026.

Article CAS PubMed Google Scholar

Mittal SK, Mashaghi A, Amouzegar A, Li M, Foulsham W, Sahu SK, et al. Mesenchymal stromal cells inhibit neutrophil effector functions in a murine model of ocular inflammation. Invest Ophthalmol Vis Sci. 2018;59:11918. https://doi.org/10.1167/iovs.17-23067.

Article CAS PubMed PubMed Central Google Scholar

Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:15975. https://doi.org/10.1038/nri3399.

Article CAS PubMed Google Scholar

Hlsdnker J, Ottmller KJ, Neeff HP, Koyama M, Gao Z, Thomas OS, et al. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset. Blood. 2018;131:1858 https://doi.org/10.1182/BLOOD-2017-10-812891.

Article PubMed PubMed Central Google Scholar

An S, Raju I, Surenkhuu B, Kwon JE, Gulati S, Karaman M, et al. Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies. Ocul Surf. 2019;17:589614. https://doi.org/10.1016/J.JTOS.2019.03.010.

Article PubMed PubMed Central Google Scholar

Byun YS, Yoo YS, Kang MJ, Whang WJ, Na KS, Mok JW, et al. Marked infiltration of neutrophils at the upper palpebral conjunctiva in patients with chronic graft-versus-host disease. Ocul Surf. 2019;17:295302. https://doi.org/10.1016/J.JTOS.2018.12.007.

Article PubMed Google Scholar

Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:23351. https://doi.org/10.1016/J.SURVOPHTHAL.2012.08.004.

Article PubMed Google Scholar

Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C, et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol. 2004;172:73938. https://doi.org/10.4049/JIMMUNOL.172.12.7393.

Article CAS PubMed Google Scholar

Stenger EO, Turnquist HR, Mapara MY, Thomson AW. Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity. Blood. 2012;119:5088 https://doi.org/10.1182/BLOOD-2011-11-364091.

Article CAS PubMed PubMed Central Google Scholar

Li H, Demetris AJ, McNiff J, Matte-Martone C, Tan HS, Rothstein DM, et al. Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction. J Immunol. 2012;188:380411. https://doi.org/10.4049/JIMMUNOL.1102795.

Article CAS PubMed Google Scholar

Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B cells in the pathogenesis of graft-versus-host disease. Blood. 2009;114:491927. https://doi.org/10.1182/BLOOD-2008-10-161638.

Article PubMed Google Scholar

Zeiser R, Blazar BR. Acute graft-versus-host diseasebiologic process, prevention, and therapy. N Engl J Med. 2017;377:216779. https://doi.org/10.1056/NEJMRA1609337/SUPPL_FILE/NEJMRA1609337_DISCLOSURES.PDF.

Article CAS PubMed PubMed Central Google Scholar

Toubai T, Mathewson ND, Magenau J, Reddy P. Danger signals and graft-versus-host disease: current understanding and future perspectives. Front Immunol. 2016;7. https://doi.org/10.3389/FIMMU.2016.00539.

Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem. 2009;284:2403548. https://doi.org/10.1074/JBC.M109.014266.

Article CAS PubMed PubMed Central Google Scholar

Koyama M, Cheong M, Markey KA, Gartlan KH, Kuns RD, Locke KR, et al. Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease. J Exp Med. 2015;212:130321. https://doi.org/10.1084/JEM.20150329.

Article CAS PubMed PubMed Central Google Scholar

Zilliox MJ, Gange WS, Kuffel G, Mores CR, Joyce C, de Bustros P, et al. Assessing the ocular surface microbiome in severe ocular surface diseases. Ocul Surf. 2020;18:70612. https://doi.org/10.1016/J.JTOS.2020.07.007.

Article PubMed PubMed Central Google Scholar

Riemens A, Stoyanova E, Rothova A, Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis. 2012;18:797.

CAS PubMed PubMed Central Google Scholar

Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550 https://doi.org/10.1016/S0140-6736(09)60237-3.

Article CAS PubMed PubMed Central Google Scholar

Korngold R, Marini JC, de Baca ME, Murphy GF, Giles-Komar J. Role of tumor necrosis factor- in graft-versus-host disease and graft-versus-leukemia responses. Biol Blood Marrow Transplant. 2003;9:292303. https://doi.org/10.1016/S1083-8791(03)00087-9.

Article CAS PubMed Google Scholar

Portero I, Gomez V, Arandojo C, Kreutzman A, Royg M, Ramirez A, et al. CCR7 as a new biomarker in graft-versus-host disease: T cells expressing the homing receptor CCR7 mediate the pathogenesis of Gvhd. Blood. 2014;124:3930 https://doi.org/10.1182/BLOOD.V124.21.3930.3930.

Article Google Scholar

Hill GR, Koyama M. Cytokines and costimulation in acute graft-versus-host disease. Blood. 2020;136:418 https://doi.org/10.1182/BLOOD.2019000952.

Article PubMed PubMed Central Google Scholar

Briones J, Novelli S, Sierra J. T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications. Bone Marrow Res. 2011;2011:17. https://doi.org/10.1155/2011/976793.

Article CAS Google Scholar

Matte-Martone C, Liu J, Jain D, McNiff J, Shlomchik WD. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Blood. 2008;111:388492. https://doi.org/10.1182/BLOOD-2007-11-125294.

Article CAS PubMed PubMed Central Google Scholar

Gallo PM, Gallucci S. The Dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol. 2013;4. https://doi.org/10.3389/FIMMU.2013.00138.

Land WG. Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells. Transpl Rev (Orlando). 2012;26:7387. https://doi.org/10.1016/J.TRRE.2011.02.003.

Article Google Scholar

Teshima T. Th1 and Th17 join forces for acute GVHD. Blood. 2011;118:47657. https://doi.org/10.1182/BLOOD-2011-09-377325.

Article PubMed Google Scholar

Herretes S, Ross DB, Duffort S, Barreras H, Yaohong T, Saeed AM, et al. Recruitment of donor T cells to the eyes during ocular GVHD in recipients of MHC-matched allogeneic hematopoietic stem cell transplants. Invest Ophthalmol Vis Sci. 2015;56:2348 https://doi.org/10.1167/IOVS.14-15630.

Article CAS PubMed PubMed Central Google Scholar

Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang XN, et al. Donor monocytederived macrophages promote human acute graft-versus-host disease. J Clin Invest. 2020;130:457486. https://doi.org/10.1172/JCI133909.

Article CAS PubMed PubMed Central Google Scholar

Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med. 1996;183:264556. https://doi.org/10.1084/JEM.183.6.2645.

Article CAS PubMed Google Scholar

Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Hung ST, et al. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood. 2008;111:247684. https://doi.org/10.1182/BLOOD-2007-08-109678.

Article CAS PubMed PubMed Central Google Scholar

Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, et al. Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood. 2005;105:20237. https://doi.org/10.1182/BLOOD-2004-08-3036.

Article CAS PubMed Google Scholar

Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood. 2001;97:288695. https://doi.org/10.1182/BLOOD.V97.9.2886.

Article CAS PubMed Google Scholar

Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA. 1999;96:930510. https://doi.org/10.1073/PNAS.96.16.9305.

Article CAS PubMed PubMed Central Google Scholar

Wang H, Yang Y-G. The complex and central role of interferon- in graft-versus-host disease and graft-versus-tumor activity. Immunol Rev. 2014;258:3044. https://doi.org/10.1111/imr.12151.

Article CAS PubMed PubMed Central Google Scholar

Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130:90 https://doi.org/10.1001/ARCHOPHTHALMOL.2011.364.

See more here:
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following ... - Nature.com

Comments are closed.